No attachments available.
R--Confirmatory Assays and Safety Pharmacology
Contact and place of performance
Growney, Matthew
Not specified
The EPA is using phenotypic and genomic screening to identify chemical bioactivity leading to hypotheses about chemical mechanism of action (MOA). In order to test MOA hypotheses, EPA requires access to a broad variety of in vitro, target-based assays and panels including binding, enzymatic and functional cellular assay formats.
The Environmental Protection Agency (EPA), through the Cincinnati Acquisition Division, has issued an award notice for solicitation 68HERC21R0026 to support confirmatory assays and safety pharmacology. The agency utilizes phenotypic and genomic screening to identify chemical bioactivity, which generates hypotheses regarding chemical mechanisms of action (MOA). To test these hypotheses, the EPA requires access to a diverse range of in vitro, target-based assays and panels, including enzymatic, binding, and functional cellular assay formats.
This requirement falls under NAICS code 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and PSC R799, Support- Management: Other. Matthew Growney is the designated point of contact for this award, which was published on December 21, 2021. No set-aside information or specific period of performance was detailed in the award metadata.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.